Dyspepsia Drug Use Pattern of Outpatients in a Public Health Center in Batununggal District Bandung
Article Sidebar
Submitted
11 January 2021
Published
30 November 2021
Keywords:
-
Dyspepsia, Drug use patterns, Outpatient
Abstract
Dyspepsia is a condition of pain in the epigastrium and a burning sensation that radiates to the chest. Dyspepsia occupies the 10th position in the 20 largest non-communicable diseases in a Public Health Center in Bandung. The heterogeneous symptoms and the absence of specific treatments can lead to irrational treatment. The research objective is to determine the pattern of drug use in patients with dyspepsia, including the right indication, the proper drug selection, the correct dose, and the proper interval of administration in a Public Health Center in Batununggal District Bandung. This study was an observational study using a cross-sectional study design that was descriptive in nature. The sampling technique employed the purposive sampling method retrospectively. The research was conducted on 104 patients diagnosed with dyspepsia with comorbidities and receiving drugs at an Outpatient Clinic in a Public Health Center in Batununggal District Bandung from January-March 2020. There were 38 male patients (36.538%) and 66 female patients (63.462%). The majority of patients were aged 56-65 years (28.846%). The most used drug class was antacids (60.448%), and the dosage form that was mostly used was tablets (40.299%). The most used single drug was antacids (51.923%), while the most used drug combination was antacids and omeprazole (23.077%). The accuracy of drug selection and the accuracy of indications were 100% correct, the accuracy of the dosage was 59.62% correct, the accuracy of the time interval for drug administration was 71% correct, and the accuracy of the duration of drug administration was 9.62% correct.
Full text article
Generated from XML file
References
1. Clarrett DM, Hachem C. Gastroesophageal Reflux Disease (GERD). Mo Med. 2018;115(3):214-8.
2. Brun R, Kuo B. Functional dyspepsia. Therap Adv Gastroenterol. 2010;3(3):145-64. doi:10.1177/1756283X10362639
3. Madisch A, Andresen V, Enck P, Labenz J, Frieling T, Schemann M. The Diagnosis and Treatment of Functional Dyspepsia. Dtsch Arztebl Int. 2018;115(13):222-32. doi:10.3238/arztebl.2018.0222
4. Sumarni, Andriani D. Hubungan Pola Makan Dengan Kejadian Dispepsia. J Keperawatan Fisioterapi. 2019;2(1):61-6. doi:10.35451/jkf.v2i1.282
5. Oustamanolakis P Tack J. Dyspepsia: organic versus functional. J Clin Gastroenterol. 2012;46(3):175-90. doi:10.1097/mcg.0b013e318241b335
6. Miwa H, Ghoshal UC, Gonlachanvit S, Gwee KA, Ang TL, Chang FY, et al. Asian Consensus Report on Functional Dyspepsia. J Neurogastroenterol Motil. 2012;18(2):150-68. doi:10.5056/jnm.2012.18.2.150
7. Syam AF, Simadibrata M, Makmun D, Abdullah M, Fauzi A, Renaldi K, et al. National Consensus on Management of Dyspepsia and Helicobacter pylori Infection. Acta Med Indones – Indones J Intern Med. 2017;49(3):279-87.
8. Dinas Kesehatan Kota Bandung. 20 Penyakit Terbesar di Puskesmas Kota Bandung Tahun 2016. Bandung (ID): Dinas Kesehatan Kota Bandung; 2016. Available from: http://data.bandung.go.id/dataset/20-penyakit-terbesar-di-puskesmas-kota-bandung/resource/f5e43fc8-4751-4afe-bc06-f78f34517064
9. Talley NJ, Goodsall T, Potter M. Functional dyspepsia. Aust Prescr. 2017;40(6):209-13. doi:10.18773/austprescr.2017.066
10. Ofori-Asenso R, Agyeman AA. Irrational Use of Medicines—A Summary of Key Concepts. Pharmacy. 2016;4(4):35. doi:10.3390/pharmacy4040035
11. Kardela W, Andrajati R, Supardi S. Perbandingan Penggunaan Obat Rasional Berdasarkan Indikator WHO di Puskesmas Kecamatan antara Kota Depok dan Jakarta Selatan. J Kefarmasian Indones. 2014;4(2):91-102.
12. Mulandani RG, Hadriyati A, Rahmadevi. Pola Penggunaan Obat Pada Pasien Dispepsia Rawat Jalan Di RSUD H. Abdul Manap Kota Jambi. Parapemikir J Ilmiah Farmasi. 2020;9(2):17-25. doi:10.30591/pjif.v9i2.1885
13. Musnelina L, Agung DGAR. Profil Kesesuaian Terapi Obat Dispepsia Terhadap Formularium Pada Pasien Rawat Jalan Rumah Sakit Tk. IV Cijantung Jakarta, Jakarta Timur, Periode Januari – Desember 2016. Sainstech Farma J Ilmu Kefarmasian. 2019;12(2):111-7. doi:10.37277/sfj.v12i2.456
14. Badan Pusat Statistik Kota Bandung. Jumlah Penduduk dan Rasio Jenis Kelamin Menurut Kecamatan di Kota Bandung Tahun 2015. Bandung (ID): Badan Pusat Statistik Kota Bandung; 2018. Available from: https://bandungkota.bps.go.id/statictable/2017/03/31/17/penduduk-kota-bandung-menurut-kecamatan-dan-rasio-jenis-kelamin-tahun-2015.html
15. Machin D, Campbell MJ. Design of Studies for Medical Research. West Sussex (UK): John Wiley & Sons Ltd; 2005.
16. Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533-44. doi:10.1007/s10488-013-0528-y
17. Masruroh A, Prabandari S, Purgiyanti. Pola Peresepan Obat Pada Pasien Dipepsia Di Puskesmas Wanasari Kabupaten Wanasari. Parapemikir J Ilmiah Farmasi. 2020;9(1):1-6.
18. Yau YHC, Potenza MN. Stress and Eating Behaviors. Minerva Endocrinol. 2013;38(3):255-67.
19. Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6(2):603-21. doi:10.1002/cphy.c150015
20. Browning KN, Travagli RA. Central Nervous System Control of Gastrointestinal Motility and Secretion and Modulation of Gastrointestinal Functions. Compr Physiol. 2014;4(4):1339-68. doi:10.1002/cphy.c130055
21. Jaber N, Oudah M, Kowatli A, Jibril J, Baig I, Mathew E, et al. Dietary and Lifestyle Factors Associated with Dyspepsia among Pre-clinical Medical Students in Ajman, United Arab Emirates. Cent Asian J Glob Health. 2016;5(1):192. doi:10.5195/cajgh.2016.192
22. Wang YK, Hsu WH, Wang SSW, Lu CY, Kuo FC, Su YC, et al. Current Pharmacological Management of Gastroesophageal Reflux Disease. Gastroenterol Res Pract. 2013;2013:983653. doi:10.1155/2013/983653
23. Lestari F, Nurmainah, Untari EK. Analisis Hubungan Peran Pengawas Menelan Obat Terhadap Kepatuhan Pasien Tuberkulosis Paru Anak di UPTD RSUD Sultan Syarif Mohamad Alkadrie Kota Pontianak. J Mahasiswa Farmasi Fakultas Kedokteran UNTAN. 2019;4(1):1-12.
24. Katzung BG, Masters SB, Trevor AJ. Basic and Clinical Pharmacology. 14th edition. New York (US): McGraw-Hill Education; 2018.
25. Lacy BE, Talley NJ, Locke GR, Bouras EP, DiBaise JK, El-Serag HB, et al. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012;36(1):3-15. doi:10.1111/j.1365-2036.2012.05128.x
26. Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in Oral Drug Delivery. Front Pharmacol. 2021;12:618411. doi:10.3389/fphar.2021.618411
27. Srikandi N, Mukaddas A, Faustine I. Profil Penggunaan Obat Pada Pasien Dispepsia Di RSU Anutapura Palu. J Farmasi Galenika Galenika J Pharm. 2017;3(2):126-31. doi:10.22487/j24428744.2017.v3.i2.8772
28. Jin J, Sklar GE, Oh VMS, Li SC. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269-86. doi:10.2147/tcrm.s1458
29. Shin JM, Sachs G. Pharmacology of Proton Pump Inhibitors. Curr Gastroenterol Rep. 2008;10(6):528-34. doi:10.1007/s11894-008-0098-4
30. Shin JM, Kim N. Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors. J Neurogastroenterol Motil. 2013;19(1):25-35. doi:10.5056/jnm.2013.19.1.25
31. Tilman EM, Smetana KS, Bantu L, Buckley MG. Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature. J Pediatr Pharmacol Ther. 2016;21(2):120-32. doi:10.5863/1551-6776-21.2.120
32. Pritchard DS, Baber N, Stephenson T. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol. 2005;59(6):725-9. doi:10.1111/j.1365-2125.2005.02422.x
33. Gyte GML, Richens Y. Routine prophylactic drugs in normal labour for reducing gastric aspiration and its effects. Cochrane Database Syst Rev 2006;2006(3):CD005298. doi:10.1002/14651858.CD005298.pub2
34. Panda V, Shinde P, Deora J Gupta P. A comparative study of the antacid effect of some commonly consumed foods for hyperacidity in an artificial stomach model. Complement Ther Med. 2017;34:111-5. doi:10.1016/j.ctim.2017.08.002
35. Palleria C, Di Paolo A, Giofrè C, Caglioti C, Leuzzi G, Siniscalchi A, et al. Pharmacokinetic drug-drug interaction and their implication in clinical management. J Res Med Sci. 2013;18(7):601-10.
36. Badan Pengawas Obat dan Makanan Republik Indonesia. Pusat Informasi Obat Nasional: Bab 1 Sistem Saluran Cerna. Jakarta (ID): Badan Pengawas Obat dan Makanan Republik Indonesia; 2015. Available from: http://pionas.pom.go.id/ioni/bab-1-sistem-saluran-cerna-0
37. Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/688/2019 tentang Daftar Obat Esensial Nasional. Jakarta (ID): Kementerian Kesehatan Republik Indonesia; 2019. Available from: http://farmalkes.kemkes.go.id/unduh/kepmenkeshk-01-07-menkes-688-20192019daftar-obat-esensial-nasional/
38. Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/659/2017 tentang Formularium Nasional. Jakarta (ID): Kementerian Kesehatan Republik Indonesia; 2017. Available from: http://hukor.kemkes.go.id/uploads/produk_hukum/KMK_No._HK_.01_.07-MENKES-659-2017_ttg_Formularium_Nasional_.pdf
39. MIMS Indonesia. MIMS. Singapore: MIMS Group; 2020. Available from: https://www.mims.com/indonesia/drug/advancedsearch
40. Coleman JJ, Pontefract SK. Adverse drug reactions. Clin Med. 2016;16(5):481-5. doi:10.7861/clinmedicine.16-5-481
41. Brown MT, Bussell JK. Medication Adherence: WHO Cares? Mayo Clin Proc. 2011;86(4):304-14. doi:10.4065/mcp.2010.0575
42. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31(3):213-24. doi:10.1007/s10865-007-9147-y
43. Ikatan Apoteker Indonesia. Informasi Spesialite Obat Indonesia. Volume 50. Jakarta (ID): ISFI Penerbitan; 2016.
44. Kang JS, Lee MH. Overview of Therapeutic Drug Monitoring. Korean J Intern Med. 2009;24(1):1-10. doi:10.3904/kjim.2009.24.1.1
45. Frykberg RG, Banks J. Challenges in the Treatment of Chronic Wounds. Adv Wound Care. 2015;4(9):560-82. doi:10.1089/wound.2015.0635
46. Guo S, DiPietro LA. Factors Affecting Wound Healing. J Dent Res. 2010;89(3):219-29. doi:10.1177/0022034509359125
47. Jin JF, Zhu LL, Chen M, Xu HM, Wang HF, Feng XQ, et al. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. Patient Prefer Adherence. 2015;9:923-42. doi:10.2147/PPA.S87271
2. Brun R, Kuo B. Functional dyspepsia. Therap Adv Gastroenterol. 2010;3(3):145-64. doi:10.1177/1756283X10362639
3. Madisch A, Andresen V, Enck P, Labenz J, Frieling T, Schemann M. The Diagnosis and Treatment of Functional Dyspepsia. Dtsch Arztebl Int. 2018;115(13):222-32. doi:10.3238/arztebl.2018.0222
4. Sumarni, Andriani D. Hubungan Pola Makan Dengan Kejadian Dispepsia. J Keperawatan Fisioterapi. 2019;2(1):61-6. doi:10.35451/jkf.v2i1.282
5. Oustamanolakis P Tack J. Dyspepsia: organic versus functional. J Clin Gastroenterol. 2012;46(3):175-90. doi:10.1097/mcg.0b013e318241b335
6. Miwa H, Ghoshal UC, Gonlachanvit S, Gwee KA, Ang TL, Chang FY, et al. Asian Consensus Report on Functional Dyspepsia. J Neurogastroenterol Motil. 2012;18(2):150-68. doi:10.5056/jnm.2012.18.2.150
7. Syam AF, Simadibrata M, Makmun D, Abdullah M, Fauzi A, Renaldi K, et al. National Consensus on Management of Dyspepsia and Helicobacter pylori Infection. Acta Med Indones – Indones J Intern Med. 2017;49(3):279-87.
8. Dinas Kesehatan Kota Bandung. 20 Penyakit Terbesar di Puskesmas Kota Bandung Tahun 2016. Bandung (ID): Dinas Kesehatan Kota Bandung; 2016. Available from: http://data.bandung.go.id/dataset/20-penyakit-terbesar-di-puskesmas-kota-bandung/resource/f5e43fc8-4751-4afe-bc06-f78f34517064
9. Talley NJ, Goodsall T, Potter M. Functional dyspepsia. Aust Prescr. 2017;40(6):209-13. doi:10.18773/austprescr.2017.066
10. Ofori-Asenso R, Agyeman AA. Irrational Use of Medicines—A Summary of Key Concepts. Pharmacy. 2016;4(4):35. doi:10.3390/pharmacy4040035
11. Kardela W, Andrajati R, Supardi S. Perbandingan Penggunaan Obat Rasional Berdasarkan Indikator WHO di Puskesmas Kecamatan antara Kota Depok dan Jakarta Selatan. J Kefarmasian Indones. 2014;4(2):91-102.
12. Mulandani RG, Hadriyati A, Rahmadevi. Pola Penggunaan Obat Pada Pasien Dispepsia Rawat Jalan Di RSUD H. Abdul Manap Kota Jambi. Parapemikir J Ilmiah Farmasi. 2020;9(2):17-25. doi:10.30591/pjif.v9i2.1885
13. Musnelina L, Agung DGAR. Profil Kesesuaian Terapi Obat Dispepsia Terhadap Formularium Pada Pasien Rawat Jalan Rumah Sakit Tk. IV Cijantung Jakarta, Jakarta Timur, Periode Januari – Desember 2016. Sainstech Farma J Ilmu Kefarmasian. 2019;12(2):111-7. doi:10.37277/sfj.v12i2.456
14. Badan Pusat Statistik Kota Bandung. Jumlah Penduduk dan Rasio Jenis Kelamin Menurut Kecamatan di Kota Bandung Tahun 2015. Bandung (ID): Badan Pusat Statistik Kota Bandung; 2018. Available from: https://bandungkota.bps.go.id/statictable/2017/03/31/17/penduduk-kota-bandung-menurut-kecamatan-dan-rasio-jenis-kelamin-tahun-2015.html
15. Machin D, Campbell MJ. Design of Studies for Medical Research. West Sussex (UK): John Wiley & Sons Ltd; 2005.
16. Palinkas LA, Horwitz SM, Green CA, Wisdom JP, Duan N, Hoagwood K. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42(5):533-44. doi:10.1007/s10488-013-0528-y
17. Masruroh A, Prabandari S, Purgiyanti. Pola Peresepan Obat Pada Pasien Dipepsia Di Puskesmas Wanasari Kabupaten Wanasari. Parapemikir J Ilmiah Farmasi. 2020;9(1):1-6.
18. Yau YHC, Potenza MN. Stress and Eating Behaviors. Minerva Endocrinol. 2013;38(3):255-67.
19. Herman JP, McKlveen JM, Ghosal S, Kopp B, Wulsin A, Makinson R, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Compr Physiol. 2016;6(2):603-21. doi:10.1002/cphy.c150015
20. Browning KN, Travagli RA. Central Nervous System Control of Gastrointestinal Motility and Secretion and Modulation of Gastrointestinal Functions. Compr Physiol. 2014;4(4):1339-68. doi:10.1002/cphy.c130055
21. Jaber N, Oudah M, Kowatli A, Jibril J, Baig I, Mathew E, et al. Dietary and Lifestyle Factors Associated with Dyspepsia among Pre-clinical Medical Students in Ajman, United Arab Emirates. Cent Asian J Glob Health. 2016;5(1):192. doi:10.5195/cajgh.2016.192
22. Wang YK, Hsu WH, Wang SSW, Lu CY, Kuo FC, Su YC, et al. Current Pharmacological Management of Gastroesophageal Reflux Disease. Gastroenterol Res Pract. 2013;2013:983653. doi:10.1155/2013/983653
23. Lestari F, Nurmainah, Untari EK. Analisis Hubungan Peran Pengawas Menelan Obat Terhadap Kepatuhan Pasien Tuberkulosis Paru Anak di UPTD RSUD Sultan Syarif Mohamad Alkadrie Kota Pontianak. J Mahasiswa Farmasi Fakultas Kedokteran UNTAN. 2019;4(1):1-12.
24. Katzung BG, Masters SB, Trevor AJ. Basic and Clinical Pharmacology. 14th edition. New York (US): McGraw-Hill Education; 2018.
25. Lacy BE, Talley NJ, Locke GR, Bouras EP, DiBaise JK, El-Serag HB, et al. Review article: current treatment options and management of functional dyspepsia. Aliment Pharmacol Ther. 2012;36(1):3-15. doi:10.1111/j.1365-2036.2012.05128.x
26. Alqahtani MS, Kazi M, Alsenaidy MA, Ahmad MZ. Advances in Oral Drug Delivery. Front Pharmacol. 2021;12:618411. doi:10.3389/fphar.2021.618411
27. Srikandi N, Mukaddas A, Faustine I. Profil Penggunaan Obat Pada Pasien Dispepsia Di RSU Anutapura Palu. J Farmasi Galenika Galenika J Pharm. 2017;3(2):126-31. doi:10.22487/j24428744.2017.v3.i2.8772
28. Jin J, Sklar GE, Oh VMS, Li SC. Factors affecting therapeutic compliance: A review from the patient’s perspective. Ther Clin Risk Manag. 2008;4(1):269-86. doi:10.2147/tcrm.s1458
29. Shin JM, Sachs G. Pharmacology of Proton Pump Inhibitors. Curr Gastroenterol Rep. 2008;10(6):528-34. doi:10.1007/s11894-008-0098-4
30. Shin JM, Kim N. Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors. J Neurogastroenterol Motil. 2013;19(1):25-35. doi:10.5056/jnm.2013.19.1.25
31. Tilman EM, Smetana KS, Bantu L, Buckley MG. Pharmacologic Treatment for Pediatric Gastroparesis: A Review of the Literature. J Pediatr Pharmacol Ther. 2016;21(2):120-32. doi:10.5863/1551-6776-21.2.120
32. Pritchard DS, Baber N, Stephenson T. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol. 2005;59(6):725-9. doi:10.1111/j.1365-2125.2005.02422.x
33. Gyte GML, Richens Y. Routine prophylactic drugs in normal labour for reducing gastric aspiration and its effects. Cochrane Database Syst Rev 2006;2006(3):CD005298. doi:10.1002/14651858.CD005298.pub2
34. Panda V, Shinde P, Deora J Gupta P. A comparative study of the antacid effect of some commonly consumed foods for hyperacidity in an artificial stomach model. Complement Ther Med. 2017;34:111-5. doi:10.1016/j.ctim.2017.08.002
35. Palleria C, Di Paolo A, Giofrè C, Caglioti C, Leuzzi G, Siniscalchi A, et al. Pharmacokinetic drug-drug interaction and their implication in clinical management. J Res Med Sci. 2013;18(7):601-10.
36. Badan Pengawas Obat dan Makanan Republik Indonesia. Pusat Informasi Obat Nasional: Bab 1 Sistem Saluran Cerna. Jakarta (ID): Badan Pengawas Obat dan Makanan Republik Indonesia; 2015. Available from: http://pionas.pom.go.id/ioni/bab-1-sistem-saluran-cerna-0
37. Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/688/2019 tentang Daftar Obat Esensial Nasional. Jakarta (ID): Kementerian Kesehatan Republik Indonesia; 2019. Available from: http://farmalkes.kemkes.go.id/unduh/kepmenkeshk-01-07-menkes-688-20192019daftar-obat-esensial-nasional/
38. Kementerian Kesehatan Republik Indonesia. Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/MENKES/659/2017 tentang Formularium Nasional. Jakarta (ID): Kementerian Kesehatan Republik Indonesia; 2017. Available from: http://hukor.kemkes.go.id/uploads/produk_hukum/KMK_No._HK_.01_.07-MENKES-659-2017_ttg_Formularium_Nasional_.pdf
39. MIMS Indonesia. MIMS. Singapore: MIMS Group; 2020. Available from: https://www.mims.com/indonesia/drug/advancedsearch
40. Coleman JJ, Pontefract SK. Adverse drug reactions. Clin Med. 2016;16(5):481-5. doi:10.7861/clinmedicine.16-5-481
41. Brown MT, Bussell JK. Medication Adherence: WHO Cares? Mayo Clin Proc. 2011;86(4):304-14. doi:10.4065/mcp.2010.0575
42. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31(3):213-24. doi:10.1007/s10865-007-9147-y
43. Ikatan Apoteker Indonesia. Informasi Spesialite Obat Indonesia. Volume 50. Jakarta (ID): ISFI Penerbitan; 2016.
44. Kang JS, Lee MH. Overview of Therapeutic Drug Monitoring. Korean J Intern Med. 2009;24(1):1-10. doi:10.3904/kjim.2009.24.1.1
45. Frykberg RG, Banks J. Challenges in the Treatment of Chronic Wounds. Adv Wound Care. 2015;4(9):560-82. doi:10.1089/wound.2015.0635
46. Guo S, DiPietro LA. Factors Affecting Wound Healing. J Dent Res. 2010;89(3):219-29. doi:10.1177/0022034509359125
47. Jin JF, Zhu LL, Chen M, Xu HM, Wang HF, Feng XQ, et al. The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection. Patient Prefer Adherence. 2015;9:923-42. doi:10.2147/PPA.S87271
Authors
1.
Suherman LP, Kartidjo P, Rukmawati I, Septiani V, Azzura F. Dyspepsia Drug Use Pattern of Outpatients in a Public Health Center in Batununggal District Bandung. Borneo J Pharm [Internet]. 2021Nov.30 [cited 2024Apr.19];4(4):345-54. Available from: https://journal.umpr.ac.id/index.php/bjop/article/view/1987
Authors continue to retain the copyright to the article if the article is published in the Borneo Journal of Pharmacy. They will also retain the publishing rights to the article without any restrictions.
Authors who publish with this journal agree to the following terms:
- Any article on the copyright is retained by the author(s).
- The author grants the journal, right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles of work (eg, post-institutional repository) or publish it in a book, with acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process, as can lead to productive exchanges, as well as earlier and greater citation of published work.
- The article and any associated published material are distributed under the Creative Commons Attribution-ShareAlike 4.0 International License.
Article Details
